Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Jiang Chang
Jiang Chang, Shanghai CN
| Patent application number | Description | Published |
|---|---|---|
| 20100192632 | Resorbable macroporous bioactive glass scaffold and method of manufacture - A method of manufacturing a resorbable, macroporous bioactive glass scaffold comprising approximately 24-45% CaO, 34-50% SiO | 08-05-2010 |
| 20110039101 | ELECTROSPUN FIBER TUBULAR MATERIAL AND PREPARATION METHOD THEREOF - A method of preparing electrospun fiber tubular material comprises: using single metal rod template or two-dimensional or three-dimensional metal rod combined-template which has cross structure and is composed of the said single metal rod templates to prepare tubular electrospun fiber material by controlling electrospinning process parameters. The method could control the macro-structure and micro-structure of the tubular electrospun fiber material by adjusting template parameters. The tubular electrospun fiber material obtained from the method could be used in such fields as biomedical material, tissue engineering scaffold, photo-electric material, filtering material and sensor etc. | 02-17-2011 |
Jiang Chang, Westfield, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090209556 | SOLUBLE GUANYLATE CYCLASE ACTIVATORS - A compound having the structure | 08-20-2009 |
| 20090209564 | Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use - Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included. | 08-20-2009 |
| 20100004158 | GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE - Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included. (I) | 01-07-2010 |
| 20100144824 | GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE - Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included. | 06-10-2010 |
| 20110118282 | Soluble Guanylate Cyclase Activators - A compound having the structure | 05-19-2011 |
Jiang Chang, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090293139 | DOUBLE-INDUCIBLE GENE ACTIVATION SYSTEM AND ITS APPLICATIONS - A double-inducible system for expressing a transgene, preferably comprising an RU486-inducible system integrated with a CID-inducible system. The invention further comprises a gene expression system for use in in vitro cell culture studies, and a gene expression expression system for use in engineering modified bigenic mice. | 11-26-2009 |
Jiang Chang, Brooklyn, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090232108 | I/Q IMBALANCE ESTIMATION USING SYNCHRONIZATION SIGNALS IN LTE SYSTEMS - A method and apparatus perform I/Q imbalance estimation and compensation using synchronization signals in LTE systems. Primary and secondary synchronization signals (P-SCH and S-SCH), which carry synchronization information, are embedded in each LTE frame, and are used for receiver I/Q imbalance estimation. Additionally, the performance may be significantly improved by optimally selecting the training data in I/Q imbalance estimation. | 09-17-2009 |